Mostra i principali dati dell'item

dc.creatorKarassa, F. B.en
dc.date.accessioned2015-11-23T10:33:33Z
dc.date.available2015-11-23T10:33:33Z
dc.date.issued2006
dc.identifier10.1056/NEJMc053503
dc.identifier.issn284793
dc.identifier.urihttp://hdl.handle.net/11615/29107
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-32644489982&partnerID=40&md5=c783bc5666823adc73e08ff461e9efc5
dc.subjectcyclophosphamideen
dc.subjectmycophenolic acid 2 morpholinoethyl esteren
dc.subjectcomparative studyen
dc.subjectdisease predispositionen
dc.subjectdrug efficacyen
dc.subjectdrug indicationen
dc.subjectdrug responseen
dc.subjecthumanen
dc.subjectkidney dysfunctionen
dc.subjectletteren
dc.subjectlupus erythematosus nephritisen
dc.subjectmembranous glomerulonephritisen
dc.subjectpriority journalen
dc.subjectremissionen
dc.titleMycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis [1]en
dc.typejournalArticleen


Files in questo item

FilesDimensioneFormatoMostra

Nessun files in questo item.

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item